STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Brishette Mendoza and ...

Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort Study A nationwide ...

Within IT, testing has matured as an industry. Many tools exist, and many IT shops have testing groups. But, often those testing groups are unable to assist on data-related projects. The heart of the ...

A study led by scientists at Johns Hopkins Bloomberg School of Public Health suggests that advanced algorithms working from large chemical databases can predict a new chemical's toxicity better than ...